Journal of Antimicrobial Chemotherapy, volume 70, issue 11, pages 2973-2980

Induced tigecycline resistance inStreptococcus pneumoniaemutants reveals mutations in ribosomal proteins and rRNA

Lupien Andréanne 1
Gingras Hélène 1
Leprohon Philippe 1
Ouellette Marc 1
1
 
Centre de recherche en Infectiologie du Centre de recherche du CHU de Québec and Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, QC, Canada
Publication typeJournal Article
Publication date2015-07-16
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor5.2
ISSN03057453, 14602091
Pharmacology
Microbiology (medical)
Infectious Diseases
Pharmacology (medical)
Abstract
Tigecycline is a broad-spectrum antibiotic acting at the level of the 30S ribosomal subunit to inhibit translation. While Streptococcus pneumoniae remains susceptible to tigecycline, resistance is beginning to emerge in some species and mainly involves efflux or mutations in ribosome constituents. We describe here the characterization of S. pneumoniae mutants selected for resistance to tigecycline.Molecular determinants of resistance to tigecycline in S. pneumoniae were studied through WGS of two series of mutants made resistant to tigecycline in vitro in a stepwise fashion and by reconstructing tigecycline resistance using DNA transformation.The tigecycline-resistant S. pneumoniae M1TGC-6 and M2TGC-6 mutants were cross-resistant to tetracycline and minocycline. A role in tigecycline resistance could be attributed to 4 of the 12 genes that were mutated in both mutants. Mutations in ribosomal proteins S10 and S3, acquired early and late during selection, respectively, were implicated in resistance in both mutants. Similarly, mutations were detected in the four alleles of the 16S ribosomal RNA at sites involved in tigecycline binding and the number of mutated alleles correlated with the level of resistance. Finally, the gene spr1784 encodes an RsmD-like 16S rRNA methyltransferase for which inactivating mutations selected in the S. pneumoniae tigecycline-resistant mutants were found to decrease susceptibility to tigecycline.This first report about tigecycline resistance mechanisms in S. pneumoniae revealed that, in contrast to Gram-negative species, for which efflux appears central for tigecycline resistance, resistance in the pneumococcus occurs through mutations related to ribosomes.

Citations by journals

1
2
3
4
5
6
7
8
Frontiers in Microbiology
Frontiers in Microbiology, 8, 24.24%
Frontiers in Microbiology
8 publications, 24.24%
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, 3, 9.09%
Antimicrobial Agents and Chemotherapy
3 publications, 9.09%
Journal of Medical Microbiology
Journal of Medical Microbiology, 2, 6.06%
Journal of Medical Microbiology
2 publications, 6.06%
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, 2, 6.06%
International Journal of Antimicrobial Agents
2 publications, 6.06%
Biochemistry (Moscow)
Biochemistry (Moscow), 1, 3.03%
Biochemistry (Moscow)
1 publication, 3.03%
American Journal of Therapeutics
American Journal of Therapeutics, 1, 3.03%
American Journal of Therapeutics
1 publication, 3.03%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 3.03%
International Journal of Molecular Sciences
1 publication, 3.03%
Molecules
Molecules, 1, 3.03%
Molecules
1 publication, 3.03%
Antibiotics
Antibiotics, 1, 3.03%
Antibiotics
1 publication, 3.03%
Veterinary Research
Veterinary Research, 1, 3.03%
Veterinary Research
1 publication, 3.03%
Aquaculture
Aquaculture, 1, 3.03%
Aquaculture
1 publication, 3.03%
Journal of Global Antimicrobial Resistance
Journal of Global Antimicrobial Resistance, 1, 3.03%
Journal of Global Antimicrobial Resistance
1 publication, 3.03%
Anaerobe
Anaerobe, 1, 3.03%
Anaerobe
1 publication, 3.03%
International Journal of Medical Microbiology
International Journal of Medical Microbiology, 1, 3.03%
International Journal of Medical Microbiology
1 publication, 3.03%
Pharmacology and Therapeutics
Pharmacology and Therapeutics, 1, 3.03%
Pharmacology and Therapeutics
1 publication, 3.03%
Microbial Pathogenesis
Microbial Pathogenesis, 1, 3.03%
Microbial Pathogenesis
1 publication, 3.03%
Drug Resistance Updates
Drug Resistance Updates, 1, 3.03%
Drug Resistance Updates
1 publication, 3.03%
Open Medicine (Poland)
Open Medicine (Poland), 1, 3.03%
Open Medicine (Poland)
1 publication, 3.03%
Chemical Reviews
Chemical Reviews, 1, 3.03%
Chemical Reviews
1 publication, 3.03%
Annals of Laboratory Medicine, 1, 3.03%
Annals of Laboratory Medicine
1 publication, 3.03%
Microbiology spectrum
Microbiology spectrum, 1, 3.03%
Microbiology spectrum
1 publication, 3.03%
Beni-Suef University Journal of Basic and Applied Sciences
Beni-Suef University Journal of Basic and Applied Sciences, 1, 3.03%
Beni-Suef University Journal of Basic and Applied Sciences
1 publication, 3.03%
1
2
3
4
5
6
7
8

Citations by publishers

1
2
3
4
5
6
7
8
9
Elsevier
Elsevier, 9, 27.27%
Elsevier
9 publications, 27.27%
Frontiers Media S.A.
Frontiers Media S.A., 8, 24.24%
Frontiers Media S.A.
8 publications, 24.24%
American Society for Microbiology
American Society for Microbiology, 4, 12.12%
American Society for Microbiology
4 publications, 12.12%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 3, 9.09%
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 9.09%
Microbiology Society
Microbiology Society, 2, 6.06%
Microbiology Society
2 publications, 6.06%
Springer Nature
Springer Nature, 2, 6.06%
Springer Nature
2 publications, 6.06%
Pleiades Publishing
Pleiades Publishing, 1, 3.03%
Pleiades Publishing
1 publication, 3.03%
Wolters Kluwer Health
Wolters Kluwer Health, 1, 3.03%
Wolters Kluwer Health
1 publication, 3.03%
Walter de Gruyter
Walter de Gruyter, 1, 3.03%
Walter de Gruyter
1 publication, 3.03%
American Chemical Society (ACS)
American Chemical Society (ACS), 1, 3.03%
American Chemical Society (ACS)
1 publication, 3.03%
Seoul National University, 1, 3.03%
Seoul National University
1 publication, 3.03%
1
2
3
4
5
6
7
8
9
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Lupien A. et al. Induced tigecycline resistance inStreptococcus pneumoniaemutants reveals mutations in ribosomal proteins and rRNA // Journal of Antimicrobial Chemotherapy. 2015. Vol. 70. No. 11. pp. 2973-2980.
GOST all authors (up to 50) Copy
Lupien A., Gingras H., Leprohon P., Ouellette M. Induced tigecycline resistance inStreptococcus pneumoniaemutants reveals mutations in ribosomal proteins and rRNA // Journal of Antimicrobial Chemotherapy. 2015. Vol. 70. No. 11. pp. 2973-2980.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1093/jac/dkv211
UR - https://doi.org/10.1093%2Fjac%2Fdkv211
TI - Induced tigecycline resistance inStreptococcus pneumoniaemutants reveals mutations in ribosomal proteins and rRNA
T2 - Journal of Antimicrobial Chemotherapy
AU - Lupien, Andréanne
AU - Gingras, Hélène
AU - Leprohon, Philippe
AU - Ouellette, Marc
PY - 2015
DA - 2015/07/16 00:00:00
PB - Oxford University Press
SP - 2973-2980
IS - 11
VL - 70
SN - 0305-7453
SN - 1460-2091
ER -
BibTex |
Cite this
BibTex Copy
@article{2015_Lupien,
author = {Andréanne Lupien and Hélène Gingras and Philippe Leprohon and Marc Ouellette},
title = {Induced tigecycline resistance inStreptococcus pneumoniaemutants reveals mutations in ribosomal proteins and rRNA},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2015},
volume = {70},
publisher = {Oxford University Press},
month = {jul},
url = {https://doi.org/10.1093%2Fjac%2Fdkv211},
number = {11},
pages = {2973--2980},
doi = {10.1093/jac/dkv211}
}
MLA
Cite this
MLA Copy
Lupien, Andréanne, et al. “Induced tigecycline resistance inStreptococcus pneumoniaemutants reveals mutations in ribosomal proteins and rRNA.” Journal of Antimicrobial Chemotherapy, vol. 70, no. 11, Jul. 2015, pp. 2973-2980. https://doi.org/10.1093%2Fjac%2Fdkv211.
Found error?